These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3536537)

  • 41. Immunotherapy of type I diabetes: rationale, results and prospects.
    Pozza G; Pastore MR; Bosi E
    Pharmacol Res; 1992 Sep; 26 Suppl 2():110-1. PubMed ID: 1409267
    [No Abstract]   [Full Text] [Related]  

  • 42. What future for therapeutic prevention of type 1 (insulin-dependent) diabetes mellitus?
    Pozzilli P; Signore A; Andreani D
    Diabetologia; 1992 Nov; 35(11):1093-5. PubMed ID: 1473621
    [No Abstract]   [Full Text] [Related]  

  • 43. Immune intervention studies in insulin-dependent diabetes mellitus.
    Skyler JS
    Diabetes Metab Rev; 1987 Oct; 3(4):1017-35. PubMed ID: 3315520
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunotherapy in type 1 diabetes.
    Pozzilli P
    Diabet Med; 1988 Nov; 5(8):734-8. PubMed ID: 2975564
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunotherapy of immune-mediated diabetes. Present and future.
    Maclaren N
    Clin Rev Allergy Immunol; 2000 Dec; 19(3):277-97. PubMed ID: 11138410
    [No Abstract]   [Full Text] [Related]  

  • 46. The SAgA of Antigen-Specific Immunotherapy for Type 1 Diabetes.
    Mallone R; You S
    Diabetes; 2021 Jun; 70(6):1247-1249. PubMed ID: 34016601
    [No Abstract]   [Full Text] [Related]  

  • 47. [Diabetes by immunotherapy].
    Manzano N; Ocampo P; Nicolini C; Halac S; Aguirre M; Rivero S; Zylberman M
    Medicina (B Aires); 2018; 78(1):60. PubMed ID: 29360082
    [No Abstract]   [Full Text] [Related]  

  • 48. A machine learning approach to predict response to immunotherapy in type 1 diabetes.
    Fousteri G; Rodrigues EM; Giamporcaro GM; Falcone M
    Cell Mol Immunol; 2021 Mar; 18(3):515-517. PubMed ID: 33318626
    [No Abstract]   [Full Text] [Related]  

  • 49. Immune intervention yes, but for what reason, for whom, when and how?
    Lernmark A
    Diabetologia; 1992 Nov; 35(11):1096-8. PubMed ID: 1473622
    [No Abstract]   [Full Text] [Related]  

  • 50. Reprogramming the lymphocyte axis for advanced immunotherapy.
    Moghimi SM; Peer D
    Adv Drug Deliv Rev; 2019 Feb; 141():1-2. PubMed ID: 31375166
    [No Abstract]   [Full Text] [Related]  

  • 51. Mechanism of removal of transfused lymphocytes.
    HEINLE RW; WEISBERGER AS; GUYTON RA
    J Lab Clin Med; 1950 Nov; 36(5):832. PubMed ID: 14784704
    [No Abstract]   [Full Text] [Related]  

  • 52. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific immunotherapy in insulin-dependent diabetes mellitus (preliminary report).
    Lohmann D; Bierwolf B; Krug J; Lampeter E; Verlohren HJ
    Exp Clin Endocrinol; 1986 Aug; 87(3):333-6. PubMed ID: 3536537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of lymphocytes and serum from probands before and after manifestation of type 1 (insulin-dependent) diabetes on rat islets in vitro.
    Köhler E; Knospe S; Rjasanowski I; Michaelis D
    Exp Clin Endocrinol; 1988 Dec; 92(2):182-8. PubMed ID: 3072214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
    Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A follow-up study of cell-mediated cytotoxicity and beta cell function in type I diabetes.
    Bierwolf B; Verlohren HJ; Lohmann D; Lampeter EF; Krug J
    Exp Clin Endocrinol; 1987 Aug; 89(3):363-7. PubMed ID: 3311778
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.